Biotech Startups

IGOR is a multi-agent AI platform, or "AI co-scientist," designed to accelerate R&D and experimental discovery by closing the loop between hypothesis and empirical validation. It targets scientists and engineers in fields such as drug discovery and semiconductor process development, helping optimize process yields, improve repeatability, and reduce waste.

1 investor

Fingerpaint Group is a life sciences marketing and agency services company offering a portfolio of specialized solutions for brands in the pharmaceutical, biotech, medical device, and animal health sectors. It serves major global pharmaceutical companies with services spanning brand development and healthcare marketing.

1 investor

Fios Genomics provides bioinformatics data analysis services for drug discovery, development, and applied research to biotechnology and pharmaceutical companies, contract research organizations, and academic institutions. The company specializes in analyzing high-dimensional datasets and converting genomic data into actionable biological insights.

1 investor

First Ascent Biomedical provides personalized cancer treatment recommendations using a proprietary live-cell testing platform that evaluates individual tumor response to 150+ FDA-approved therapies. The company serves oncologists and cancer patients, delivering treatment insights within approximately 10 days to enable faster, more effective care decisions.

1 investor

FitBiomics develops proprietary probiotic microbes derived from research on the microbiomes of elite athletes and healthy people, offering products such as Nella and V•Nella that are tested for quality, safety, and efficacy. The company operates in the biotech and consumer wellness space, focused on functional health benefits.

1 investor

FitnessGenes provides personalized health guidance based on DNA, blood, and wearable data to help people identify health risks early and take preventive action. The platform serves individuals seeking to extend healthy lifespan through data-driven insights grounded in genetic analysis.

1 investor

Five Alarm Bio develops pharmaceutical compounds targeting a novel aging mechanism to prevent and treat age-related chronic diseases. The company uses chemical synthesis and screening, along with cellular and animal models, to identify small molecules that restore cellular defense mechanisms against chemical damage associated with aging.

1 investor

Flagship Biosciences is a CLIA-certified, CAP-accredited spatial biology and biomarker services company that combines AI-powered tissue analysis with scientific consultation. It serves pharmaceutical and biotech companies in drug development and diagnostics.

1 investor

Fletcher Bio engineers natural immune proteins using protein design to create precision immunotherapies that target and eliminate autoreactive T cells. The company focuses on autoimmune diseases, aiming to restore immune balance for conditions with high unmet need.

1 investor

Floaxiom develops NanoSurface, a biologically manufactured affinity nanoparticle platform for antibody (mAb) purification, offering a chromatography-free alternative to protein A resin columns and membrane systems. It targets biomanufacturing process development teams with suspension-based capture (NanoFlo) integrated into tangential flow filtration and magnetic bead (NanoMag) formats.

1 investor

Flomics develops liquid biopsy tests using next-generation sequencing and machine learning to detect cancer and other complex diseases from blood samples for clinical diagnostics. The company also provides end-to-end genomics solutions including data generation, analysis, and bioinformatics support for research and clinical projects.

1 investor

FloraWorks develops rare and novel cannabinoid-based therapeutic ingredients, focusing on non-intoxicating cannabinoids validated through peer-reviewed research and toxicology testing. It targets the health, wellness, and supplement markets, aiming to bring scientifically validated cannabinoid products to mainstream retailers.

1 investor

Flourish Research operates a network of clinical trial research sites specializing in patient recruitment and retention across therapeutic areas including cardiometabolic disease, neuroscience, oncology, and infectious diseases. The company serves pharmaceutical sponsors and contract research organizations (CROs) by providing integrated site infrastructure, patient access, and standardized operations for studies across all research phases.

1 investor

flowbone develops a first-in-class injectable bioactive hydrogel that triggers the body to deposit its own minerals and form new bone, aimed at preventing osteoporotic hip fractures. It is a preclinical-stage medical technology company spun off from EPFL's Laboratory of Biomechanical Orthopedics, with products still in development.

1 investor

Yokogawa Fluence Analytics develops patented process analytics and control technologies, including its ACOMP system for real-time polymer reaction monitoring and its ARGEN static light scattering instrument for biopolymer stability testing. It serves polymer and biopharmaceutical manufacturers and researchers worldwide, and was acquired by Yokogawa Electric Corporation in January 2023.</parameter> <parameter name="founders">[]

1 investor

FluidForm Bio builds living human tissue using its FRESH 3D bioprinting technology, which forms tissue from cells and proteins for use in pharma, medical device, and regenerative medicine applications. The company partners with life science companies and combines 3D printing, computational and synthetic biology, AI, and materials science to develop tissue for treating disease.

1 investor

Fluidic Sciences develops in-solution technologies and instruments for protein interaction analysis, enabling researchers to measure how proteins interact without immobilization complexities. The company serves biomedical scientists and researchers seeking faster, more accurate understanding of molecular interactions.

1 investor

Fluorobiotech manufactures recombinant antigens for infectious disease diagnostics, including a comprehensive panel of HIV antigens for serological and fourth-generation assays. The company supplies high-quality diagnostic reagents to researchers and diagnostic manufacturers for assay development and commercial applications.

1 investor

FlutteSpace is an AI-powered medical technology company that reimagines radiology workflows by combining machine learning with radiologist expertise. The startup serves radiologists and healthcare providers globally to improve diagnostic quality and healthcare accessibility.

1 investor

FlyUP Bio develops black soldier fly (Hermetia illucens) farming technology to convert food-industry and agricultural by-products and biowaste into animal-feed proteins, lipids, and organic fertilizer (frass). A spinoff of the Ruđer Bošković Institute, it currently sells live and dried BSF larvae, primarily as pet food, in Croatia.

1 investor

Foamlab develops bio-nanocellulose foam grown by microorganisms through fermentation, offering compostable, tunable alternatives to oil-based plastics and foams. Its materials target applications such as protective and thermal packaging, insulation, textiles and footwear, furniture, cosmetics, and aviation and automotive uses.

1 investor

Fontana Biosciences is a life sciences company based in Boston. The page provides only contact information and does not describe the company's specific products or focus.

1 investor

Protecting and restoring natural ecosystems, one plant cell at a time.

1 investor

ForeLight develops indoor, LED-driven photobioreactor systems for producing microalgae, aiming to lower the energy, labor, and capital costs of indoor cultivation. Its platform targets agricultural raw material markets including food ingredients, pharmaceuticals, animal and pet feed, and cosmetics.

1 investor